Entrectinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Entrectinib
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Entrectinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

6 API Suppliers, 1 NDC API, 5 Listed Suppliers

6 API Suppliers
1 NDC API
5 Listed Suppliers

DEVELOPMENTS

30 Drugs in Development

30 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 5 FDA Orange Book, 2 Europe, 2 Canada, 1 Australia, 2 South Africa

12 FDF Dossiers
5 FDA Orange Book
2 Europe
2 Canada
1 Australia
2 South Africa

DIGITAL CONTENT

31 News #PharmaBuzz

31 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices

1 US Medicaid Prescriptions
2 Regulatory FDF Prices

PATENTS & EXCLUSIVITIES

38 US Patents, 12 US Exclusivities, 8 Health Canada Patents

38 US Patents
12 US Exclusivities
8 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Gowling WLG (Canada) LLP

filter Patent Reset all filters

8 All

01 22693901

02 22873979

03 22933623

04 23024208

filter Product Reset all filters

8 All

01 8ENTRECTINIB

filter Dosage Reset all filters

8 All

01 8CAPSULE

filter Exp Date Reset all filters

8 All

01 22028-07-08

02 22033-05-22

03 22035-02-19

04 22037-05-18

Product Main Page

01

Gowling WLG (Canada) LLP

ENTRECTINIB

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-07-08

Date Granted : 2015-12-29

ENTRECTINIB

Brand Name : ROZLYTREK

Patent Number : 2693901

Filing Date : 2008-07-08

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-07-08

Date Granted : 2015-12-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

ENTRECTINIB

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-05-22

Date Granted : 2019-11-12

ENTRECTINIB

Brand Name : ROZLYTREK

Patent Number : 2873979

Filing Date : 2013-05-22

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-05-22

Date Granted : 2019-11-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

ENTRECTINIB

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-07-08

Date Granted : 2015-12-29

ENTRECTINIB

Brand Name : ROZLYTREK

Patent Number : 2693901

Filing Date : 2008-07-08

Strength per Unit : 200 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-07-08

Date Granted : 2015-12-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

ENTRECTINIB

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-05-22

Date Granted : 2019-11-12

ENTRECTINIB

Brand Name : ROZLYTREK

Patent Number : 2873979

Filing Date : 2013-05-22

Strength per Unit : 200 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2033-05-22

Date Granted : 2019-11-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gowling WLG (Canada) LLP

ENTRECTINIB

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-02-19

Date Granted : 2022-05-17

ENTRECTINIB

Brand Name : ROZLYTREK

Patent Number : 2933623

Filing Date : 2015-02-19

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-02-19

Date Granted : 2022-05-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gowling WLG (Canada) LLP

ENTRECTINIB

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-05-18

Date Granted : 2022-07-26

ENTRECTINIB

Brand Name : ROZLYTREK

Patent Number : 3024208

Filing Date : 2017-05-18

Strength per Unit : 100 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-05-18

Date Granted : 2022-07-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Gowling WLG (Canada) LLP

ENTRECTINIB

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-02-19

Date Granted : 2022-05-17

ENTRECTINIB

Brand Name : ROZLYTREK

Patent Number : 2933623

Filing Date : 2015-02-19

Strength per Unit : 200 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-02-19

Date Granted : 2022-05-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Gowling WLG (Canada) LLP

ENTRECTINIB

World Drug Safety EU

Not Confirmed

Gowling WLG (Canada) LLP

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2037-05-18

Date Granted : 2022-07-26

ENTRECTINIB

Brand Name : ROZLYTREK

Patent Number : 3024208

Filing Date : 2017-05-18

Strength per Unit : 200 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2037-05-18

Date Granted : 2022-07-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!